PHARMASTRAT CONSULTING APS: Financial statements 2023
CVR: 43346318
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMASTRAT CONSULTING APS (CVR 43346318) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -7,925 and a net result of DKK 1,787,613 compared with DKK 25,000 the year before. Equity in the 2023 report amounted to DKK 2,694,741. The solvency ratio was 98.7%.
- Gross Profit
- DKK -7,925
- Profit/Loss
- DKK 1,787,613
- Equity
- DKK 2,694,741
- Total Assets
- DKK 2,729,826
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMASTRAT CONSULTING APS has published its annual report for 2022. Gross profit came to DKK 260,263, and the net result was DKK 25,000.
About PHARMASTRAT CONSULTING APS
PHARMASTRAT CONSULTING APS is a Danish company of the type Anpartsselskab based in København SV, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Nicolas Clément Tipsmark Bouchet. The company is owned by Nicolas Clément Tipsmark Bouchet. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,120 and a net result of DKK -29,821 compared with DKK -3,991 the year before. Equity in the 2025 report amounted to DKK 2,470,929.